COLGATE-PALMOLIVE INDIA STOCK FALLS 3% AS BROKERAGES TURN CAUTIOUS

Colgate-Palmolive (India) fell more than 3 percent in morning trading today after brokerages adopted a cautious stance on the company’s near-term earnings outlook following its Q1 FY27 results. Concerns are centered on higher investments in advertising, brand building and premiumisation, which could weigh on profitability. The stock was down around 3.1 percent, making it one of the top midcap losers, while it has declined 8.7 percent so far in 2026. The company currently has a market capitalisation of more than Rs 52,000 crore. Analysts expect revenue growth to remain supported by improving volumes, pricing and the company’s focus on premium products. However, they cautioned that higher advertising and brand investments could result in earnings growth lagging revenue growth and limit margin expansion. CLSA retained its Hold rating with a target price of Rs 2,024, noting that Colgate’s strong gross margins provide room for increased advertising expenditure. Around 60 percent of the company’s advertising spending is digital, which is supporting faster growth in premium products. CLSA, however, lowered its earnings estimates to account for higher advertising costs and warned that elevated investments could continue amid intensifying competition. Colgate-Palmolive India reported a 7 percent year-on-year rise in net profit in Q1 FY27, while revenue increased 11.8 percent. EBITDA rose 6.7 percent, although the EBITDA margin narrowed to 31.6 percent from the year-ago quarter. The results indicate healthy top-line momentum, but investors are increasingly focused on whether higher investments in growth and premiumisation can generate stronger earnings without putting sustained pressure on margins. While most brokerages remain cautious, one brokerage maintained a bullish view and sees more than 30 percent potential upside, expecting the company’s increased growth investments to translate into stronger revenue growth over the longer term.